Crescent Biopharma
CBIO
#6946
Rank
S$0.96 B
Marketcap
S$25.87
Share price
-2.01%
Change (1 day)
N/A
Change (1 year)

Crescent Biopharma (CBIO) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : S$24.66 Million

According to Crescent Biopharma's latest financial reports the company's total liabilities are S$24.66 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Crescent Biopharma - Total liabilities on balance sheet (from 2025 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$47.86 M-31.08%
2024-12-31S$69.45 M